title: The effects of parathyroid hormone applied at different regimes on the trochanteric region of the femur in ovariectomized rat model of osteoporosis.
abstract: This study aims to investigate the effects of two application frequencies of parathyroid hormone on the trochanteric region of rat femur. Forty-three-month-old female Sprague-Dawley rats were divided into 4 groups (n = 10/group). Three groups were ovariectomized, and 8 weeks later they were administered the following treatments (5 weeks): soy-free diet (OVX), subcutaneously injected PTH (0.040 mg/kg) 5 days a week (PTH 5x/w), subcutaneously injected PTH (0.040 mg/kg) every 2 days (PTH e2d), and a sham group. The values of the biomechanical and histomorphometric parameters showed higher results in 5x/w animals in comparison to the OVX and PTH 2ed groups. The ratio between bone diameter/marrow diameter (B.Dm/Ma.Dm) in subtrochanteric cross sections did not show any significant differences between PTH 5x/w and PTH e2d. The increased bone formation rate was observed under PTH treatment in both groups mainly at the endosteal side. The endosteum seems here to be one of the targets of PTH with an accelerate bone formation and a pronounced filling-in of intracortical cavities with higher intensity for the PTH 5x/w in comparison to PTH e2d rats.
authors: Department of Trauma and Reconstructive Surgery, Georg-August-University of Goettingen, 37075 Goettingen, Germany.
authors: M
authors: M
authors: Tezval
authors: A
authors: A
authors: Banhardt
authors: S
authors: S
authors: Sehmisch
authors: L
authors: L
authors: Kolios
authors: U
authors: U
authors: Schmelz
authors: K M
authors: KM
authors: Stuermer
authors: E K
authors: EK
authors: Stuermer
references: Bone Miner. 1991 Dec;15(3):175-91
references: 1773131
references: Clin Geriatr Med. 2003 May;19(2):415-32
references: 12916294
references: Planta Med. 2010 Feb;76(3):235-40
references: 19764010
references: Bone. 1997 Sep;21(3):261-7
references: 9276091
references: Endocrinology. 2009 Apr;150(4):1570-9
references: 19022894
references: Eur J Endocrinol. 2002 Mar;146(3):431-8
references: 11888851
references: J Bone Miner Res. 2004 Jul;19(7):1165-71
references: 15177000
references: Endocrinology. 2003 May;144(5):2008-15
references: 12697709
references: J Bone Miner Res. 2009 Feb;24(2):209-20
references: 18847326
references: Spine (Phila Pa 1976). 2009 Sep 1;34(19):2014-21
references: 19730209
references: N Engl J Med. 2007 Aug 30;357(9):905-16
references: 17761594
references: J Bone Miner Res. 2006 Jan;21(1):89-96
references: 16355277
references: Comp Med. 2008 Oct;58(5):424-30
references: 19004367
references: J Orthop Res. 2007 Nov;25(11):1454-64
references: 17557320
references: Osteoporos Int. 2010 Feb;21(2):251-61
references: 19436940
references: Tohoku J Exp Med. 1998 Oct;186(2):131-41
references: 10223616
references: Calcif Tissue Int. 1997 Oct;61(4):336-44
references: 9312205
references: Calcif Tissue Int. 2006 Oct;79(4):262-72
references: 16969596
references: J Bone Miner Res. 1987 Dec;2(6):595-610
references: 3455637
references: Biochem Biophys Res Commun. 2009 Mar 20;380(4):791-6
references: 19338754
references: J Bone Miner Res. 2002 May;17(5):808-16
references: 12009011